| dc.contributor.author | Tellaloglu, S | |
| dc.contributor.author | Ziylan, O | |
| dc.contributor.author | Ander, H | |
| dc.contributor.author | Nane, I | |
| dc.contributor.author | Kocak, T | |
| dc.contributor.author | Esen, T | |
| dc.date.accessioned | 2021-03-04T14:17:07Z | |
| dc.date.available | 2021-03-04T14:17:07Z | |
| dc.date.issued | 1997 | |
| dc.identifier.citation | Nane I., Ziylan O., Esen T., Kocak T., Ander H., Tellaloglu S., "Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: A clinical trial", UROLOGY, cilt.49, sa.1, ss.108-111, 1997 | |
| dc.identifier.issn | 0090-4295 | |
| dc.identifier.other | av_80c1369a-d041-4c54-a157-12d1fb074e4d | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/87805 | |
| dc.identifier.uri | https://doi.org/10.1016/s0090-4295(96)00359-7 | |
| dc.description.abstract | Objectives. The effect of intranasal gonadotropin-releasing hormone (GnRH) and intramuscular human chorionic gonadotropin (hCG) in the treatment of cryptorchidism was investigated in 48 prepubertal boys. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Nefroloji | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ÜROLOJİ VE NEFROLOJİ | |
| dc.title | Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: A clinical trial | |
| dc.type | Makale | |
| dc.relation.journal | UROLOGY | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 49 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 108 | |
| dc.identifier.endpage | 111 | |
| dc.contributor.firstauthorID | 118280 | |
